Cost Effectiveness Analysis of Boceprevir (BOC) Added to...

Cost Effectiveness Analysis of Boceprevir (BOC) Added to Pegifn/Ribavirin (P/R) Versus Pegifn/Ribavirin (Current Standard of Care) for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Greece

Athanasakis, K., Karampli, E., Retsa, M.P., Theodoropoulou, T., Kyriopoulos, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2013.08.175
Date:
November, 2013
File:
PDF, 59 KB
english, 2013
Conversion to is in progress
Conversion to is failed